Insights & Perspectives

Filter by

Therapeutic Area / Research

Search Insights:
Showing 1 to 10 of 527
Filter by: Unfiltered

Blog Post | Jun 18, 2018

Driving Success in the Healthcare Growth Markets

China, Brazil, India, Korea, Taiwan, and Central and Eastern Europe all present strong opportunities for growth, but right now, the most opportunity exists in China.

Read more | | Share

Blog Post | Jun 5, 2018

For Cyramza, a small portion of the hepatocellular carcinoma market is in reach for patients with high baseline alpha-fetoprotein expression

Co-authored by Arnold DuBell, Ph.D., MBA

Read more | | Share

Blog Post | Jun 4, 2018

Keytruda Poised for Another Knockout as Chemotherapy Combination Expands Its Reach to Squamous Histology in First-Line NSCLC

Co-Authored by Stephanie Hawthorne, Ph.D.

Read more | | Share

Article | May 8, 2018

Kantar Health Launches Health Consumer Approach

Read more | | Share

Infographic | Apr 25, 2018

Asthma Infographic

Learn about asthma suffers and their triggers.

View Infographic | | Share

Blog Post | Apr 24, 2018

Quality Doesn't Cost – It Pays!

Quality is not a law, and organizations do not have to subscribe to the principles of it. However, for those that choose to embrace and invest in data quality, it pays off – and often significantly! An organization' s commitment to data quality attracts customers, generates revenue, and builds and maintains an organization’s reputation. Plus, an organization’ s global standard of quality supports regulatory compliance as well.

Read more | | Share

Article | Apr 24, 2018

Hay fever on the rise in the UK, as Spring springs

Read more | | Share

Blog Post | Apr 18, 2018

Waiting to exhale as three distinct checkpoint combinations read out in first-line NSCLC at AACR

After anxiously awaiting readout from 3 pivotal trials of immunotherapy in NSCLC, we can finally take a breath to process what we learned at AACR 2018: KEYNOTE-189, IMpower 150, and CheckMate 227 all presented positive results yesterday. While the individual and cross-trial interpretations of these studies is complex, the near-term impact on the treatment of NSCLC appears rather simple.

Read more | | Share

White Paper | Apr 16, 2018

Quality Doesn't Cost, It Pays

Quality is not a law, and organizations do not have to subscribe to the principles of quality. However, for those that choose to invest in it, putting quality processes in place pays off – and often significantly.

Read more | | Share

Article | Apr 10, 2018

Uncovering Patient-Centered Insights

Read more | | Share
Page  < 12345678910 >